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Introduction 
During pre-implantation development, the first differentiation event is the segregation between the 
inner cell mass (ICM) and trophectoderm. Subsequently, the ICM undergoes a second lineage 
differentiation resulting in epiblast and hypoblast lineages. Different transcription factors have been 
implicated in the specification of these different cell types, e.g. GATA4 and GATA6 (hypoblast) and 
NANOG (epiblast). Since cell fate is determined by transcriptional profiles, small molecules that 
affect specific signaling pathways have recently been shown to influence the first lineage 
commitments. For example, blockade of the MEK/Erk signaling pathway led to the suppression of 
hypoblast development in mouse embryos. In this study, we investigated the effect of different 
small molecules and cytokines on lineage commitment during mouse early embryo development.  
Materials and methods 
 
Metaphase-II stage oocytes were collected from B6D2/F1 mice and artificially activated by 10mM 
strontium chloride and 2µg/ml cytochalasin-D for 4 hours. Reconstructed oocytes were randomized 
to the different culture groups in sequential KSOM and Cook Blastocyst medium. It has been shown 
that Nanog and Klf2 represent two key transcription factors for maintaining the pluripotent state of 
embryonic stem cells which are regulated by the Transforming Growth Factor(TGF) β & JAK/STAT3 
pathway and the protein kinase A(PKA) pathway respectively, amongst others. In a first set of 
experiments, the effect of activation (50 ng/ml Activin A) or inhibition (10µM SB431542) of the 
TGFβ pathway, stimulation of JAK/STAT3 pathway (1000Units/ml LIF) and activation of the PKA 
pathway (10µM forskolin) on lineage commitment was investigated by supplementation from the 2-
cell stage onwards in 185 parthenogenetic mouse embryos. In a second set of experiments, a dose 
dependent effect of SB431542 supplementation (0, 5, 10, 20 and 30µM) on mouse embryonic 
lineage segregation was studied in 153 2-cell embryos. On day 5, all blastocysts were scored and 
fixed (excluding cavitated blastocysts) for immunostaining to analyze the second lineage 
segregation, by determination of the number of Nanog and Gata-4 positive cells in the ICM.  
Results  
In the first series, similar developmental potential to the blastocyst stage was observed in all 
groups with blastocysts formation rate >90%. The number of Nanog+cells was significantly higher 
in the group supplemented with SB431542 compared to all other groups (p<0.01). Oppositely, 
significantly lower number of Nanog+ and Gata4+ cells were present in the Activin A treated group 
compared to the control. The number of Nanog+ and Gata4+ cells in the Forskolin and LIF treated 
group remained similar to the control. 
No difference was observed in developmental potential of embryos when different concentrations of 
SB431542 were used. A significant higher number of Nanog+cells was observed when SB431542 
was used at concentration ranges between 5-20µM (5µM: 14.09±4.19; 10µM: 13.75±3.13; 20µM: 
13.04±4.03, p<0.01) compared to control group (9.083±3.32). However, the number of 
Nanog+cells was similar between control and 30 µM SB431542 (7.35±2.64). Interestingly, the 
number of Gata4+ cells was significantly reduced in the 20µM SB431542 group (7.88±2.48; 
p<0.01) compared to the control (11±4.28). Similarly, a significantly reduced number of Gata4+ 
cells was found in the 30µM SB431542 group (3.76±1.88; p<0.001) compared to all other groups.  
Conclusions 
In our setting, the second lineage segregation remained unaffected by the activation of PKA 
pathway by forskolin or JAK/STAT3 pathway by LIF. Activation of the TGFβpathway resulted in a 
decreased number of epiblast and hypoblast cells compared to control. Interestingly, inhibition of 
this TGFβ pathway by SB431542 resulted in the allocation of more ICM towards the epiblast 
lineage. By increasing the concentration of SB431542, a similar decrease in hypoblast commitment 
was observed. It remains to be determined whether this induced higher number of pluripotent 
Nanog positive cells improves stem cell derivation efficiency.  
 
